In conclusion, HO-1 serves as a potentially crucial anti-inflammatory, antioxidant, immunomodulator and bone modulator in the context of periodontitis, necessitating comprehensive exploration to ascertain the bioavailability and safety of HO-1-targeted therapeutic agents. Here, HMOX1 is linked to periodontitis.